Yasuhiko Nishioka

18PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyNanomedicineMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 26, 2026
Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two-Center Retrospective Study.

|May 26, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC.

|Jan 20, 2026
Cancer-Specific Antihuman Podoplanin Antibody chLpMab-2f Exerts Antitumor Effects Against Pleural Mesothelioma.

Aito Yoshida, Shinji Abe, Toshihiro Izumi

|Dec 17, 2024
Effects of nintedanib on circulating biomarkers of idiopathic pulmonary fibrosis.

R Gisli Jenkins, Vincent Cottin, Yasuhiko Nishioka

|Nov 04, 2024
Fibrocytes in tumor microenvironment: Identification of their fraction and novel therapeutic strategy.

Atsushi Mitsuhashi, Yasuhiko Nishioka

|Oct 03, 2024
Isolated adrenocorticotropic hormone deficiency presenting with arthritis: A case report.

Yuya Yamashita, Seidai Sato, Kaori Nii

Pageof 3

Frequent Collaborators

7 joint publications

Hiroshi Nokihara

4 joint publications

Eiji Takeuchi

2 joint publications

Yukinari Kato

2 joint publications

Vincent Cottin